Objective: The burden of cancer prevalence and mortality poses challenges to global cancer care delivery, particularly impacting low- and middle-income countries in accessing evidence-based cancer prevention, treatment, and supportive care. Integrative oncology integrates traditional, complementary, and integrative medicine with standard cancer therapies to enhance healthcare delivery. This study aims to evaluate the anti-cancer properties of kombucha tea across multiple cancer types. Materials and Methods: Various databases, including PubMed, Science Direct, and Scopus, reviewed for recent research on kombucha tea's potential benefits and impact on cancer. Results: Recent research developments highlight kombucha tea as a potential aid in enhancing cancer resistance and offering various health benefits. Conclusion: Integrative oncology, complemented by the consumption of kombucha tea, presents a promising approach to addressing the complexities of cancer care. Further exploration and updates on kombucha tea anti-cancer properties against breast, lung, liver, colorectal, ovarian, uterine, and prostate cancers are warranted to enhance comprehensive understanding and potential therapeutic applications.
Sarshar et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: